Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
FANCM protein truncating variants (PTVs) are emerging as risk factors for ER-negative and triple negative breast cancer. Here, we discuss evidence that greatest risk associates with PTVs, such as p.Arg658*, that extensively truncate the 2048 amino acid FANCM protein. Moreover, risks associated with...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-021-00338-1 |
id |
doaj-104eda8a91d541078387d85e7e6c593d |
---|---|
record_format |
Article |
spelling |
doaj-104eda8a91d541078387d85e7e6c593d2021-10-03T11:45:53ZengNature Publishing Groupnpj Breast Cancer2374-46772021-09-01711310.1038/s41523-021-00338-1Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancerPaolo Peterlongo0Gisella Figlioli1Andrew J. Deans2Fergus J. Couch3Genome Diagnostics Program, IFOM – The FIRC Institute for Molecular OncologyGenome Diagnostics Program, IFOM – The FIRC Institute for Molecular OncologyGenome Stability Unit, St Vincent’s Institute, FitzroyDepartments of Health Sciences Research, Laboratory Medicine and Pathology, and Oncology, Mayo ClinicFANCM protein truncating variants (PTVs) are emerging as risk factors for ER-negative and triple negative breast cancer. Here, we discuss evidence that greatest risk associates with PTVs, such as p.Arg658*, that extensively truncate the 2048 amino acid FANCM protein. Moreover, risks associated with other less-truncating FANCM PTVs such as p.Gln1701* and p.Gly1906Alafs12* may be amplified by additional gene variants acting as modifiers. Further studies need to be conducted taking into considerations these aspects.https://doi.org/10.1038/s41523-021-00338-1 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Paolo Peterlongo Gisella Figlioli Andrew J. Deans Fergus J. Couch |
spellingShingle |
Paolo Peterlongo Gisella Figlioli Andrew J. Deans Fergus J. Couch Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer npj Breast Cancer |
author_facet |
Paolo Peterlongo Gisella Figlioli Andrew J. Deans Fergus J. Couch |
author_sort |
Paolo Peterlongo |
title |
Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer |
title_short |
Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer |
title_full |
Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer |
title_fullStr |
Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer |
title_full_unstemmed |
Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer |
title_sort |
protein truncating variants in fancm and risk for er-negative/triple negative breast cancer |
publisher |
Nature Publishing Group |
series |
npj Breast Cancer |
issn |
2374-4677 |
publishDate |
2021-09-01 |
description |
FANCM protein truncating variants (PTVs) are emerging as risk factors for ER-negative and triple negative breast cancer. Here, we discuss evidence that greatest risk associates with PTVs, such as p.Arg658*, that extensively truncate the 2048 amino acid FANCM protein. Moreover, risks associated with other less-truncating FANCM PTVs such as p.Gln1701* and p.Gly1906Alafs12* may be amplified by additional gene variants acting as modifiers. Further studies need to be conducted taking into considerations these aspects. |
url |
https://doi.org/10.1038/s41523-021-00338-1 |
work_keys_str_mv |
AT paolopeterlongo proteintruncatingvariantsinfancmandriskforernegativetriplenegativebreastcancer AT gisellafiglioli proteintruncatingvariantsinfancmandriskforernegativetriplenegativebreastcancer AT andrewjdeans proteintruncatingvariantsinfancmandriskforernegativetriplenegativebreastcancer AT fergusjcouch proteintruncatingvariantsinfancmandriskforernegativetriplenegativebreastcancer |
_version_ |
1716845246595203072 |